Latest News

YouTube’s newest ad annoyance is testing the patience of mobile viewers

March 4, 2026 at 09:08 AM
By Aamir Siddiqui
YouTube’s newest ad annoyance is testing the patience of mobile viewers
A new overlay ad banner on Android and iOS reportedly persists even after users hit the dismiss button.

💡Analysis & Context

A new overlay ad banner on Android and iOS reportedly persists even after users hit the dismiss button A new overlay ad banner on Android and iOS reportedly persists even after users hit the dismiss button. Monitor developments in YouTube’s for further updates.

📋 Quick Summary

A new overlay ad banner on Android and iOS reportedly persists even after users hit the dismiss butt

A new overlay ad banner on Android and iOS reportedly persists even after users hit the dismiss button.
Share:

Original Source:

Read full article at source

Help us improve this article. Share your feedback and suggestions.

Related Articles

📰

Optimum will give you fiber internet for $25 a month - here's how to qualify

Optimum's new '$25 for 5' offer locks in broadband internet at an affordable price. Here are the details.

Mar 4, 2026
I’d pay for YouTube Premium if it stopped spoiling everything

I’d pay for YouTube Premium if it stopped spoiling everything

If Premium means control, this is the control we’re missing.

Mar 4, 2026
6 Horrifying Fictional Diseases and Their Real-Life Inspirations

6 Horrifying Fictional Diseases and Their Real-Life Inspirations

The Ebola virus, Cordyceps fungi, and even the stomach flu have helped inspire some of the most gruesome infectious diseases seen on the screen.

Mar 4, 2026
How Is Kalshi Not Gambling?

How Is Kalshi Not Gambling?

Kalshi lets you place bets on everything from football games to foreign invasions. The prediction market’s CEO, Tarek Mansour, says this doesn’t count as gambling—and is actually good for society.

Mar 4, 2026
📰

Eight Sleep raises $50M at $1.5B valuation

Eight Sleep said it was free-cash-flow positive in 2025, and plans to use the new funding for new products, global expansions, and clinical validation.

Mar 4, 2026

Cookie Consent

We use cookies to enhance your browsing experience, analyze site traffic, and serve personalized ads. By clicking "Accept", you consent to our use of cookies. You can learn more about our cookie practices in our Privacy Policy.